Roundtable discussion: management issues in didanosine therapy.
A
A
Carr
R
R
Penny
D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000188:drug therapy*; D006282:Health Personnel; D006801:Humans; D016273:Occupational Exposure; D010195:Pancreatitis / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D016049:Didanosine